Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:http://oc1dean.blogspot.com/2010/11/my-background-story_8.html

Tuesday, January 31, 2017

Top Ten Medical Research Issues and Trends to Watch in 2017

 I expect our fucking failures of stroke associations will do nothing with this.  No direct relation but we fit under 4, 5,6 and 8.
http://www.huf, fingtonpost.com/margaret-anderson/top-ten-medical-research_b_13975834.html
2016 will go down as a year that taught us to question our assumptions. The election of Donald Trump, an outcome almost no one predicted, left many with a sense of uncertainty about what 2017 will bring in the biomedical and health-care space. To bring clarity to these unsure times, FasterCures has compiled a list of issues critical to the future of medical innovation that we’ll be tracking over the coming year. While some issues will be closely linked with the people and policies of the new presidential administration, we think all will be important to continuing the progress toward faster cures and treatments.
1. FDA: What is the roadmap going forward?

2. What size would you like: small, medium or big science?

3. Clinical trial innovation and reform: It’s a big job but somebody’s gotta do it.

4. Doing science in the real world.

5. Patient-centricity: What’s the ROI?

6. Move over direct-to-consumer ads - it’s time for direct-to-patient R&D.

7. Digitization of disease, and health.

8. Data sharing: Where there’s a will, there needs to be a way.

9. Evolution of value frameworks.

10. Blockchain could be good for your health.


No comments:

Post a Comment